ZVSA ZyVersa Therapeutics Inc

---

Class A Common Stock, par value $0.0001 per share

(Title of Class of Securities)

98987D102

(CUSIP Number)

December 31, 2022

(Date of Event which Requires Filing of this Statement)

---

---

---

---

---

(1)	Solely in its capacity as the general partner of Oaktree Capital I, L.P.

---

---

Item 1(a).

Name of Issuer:

Item 1(b).

Address of Issuer’s Principal Executive Offices:

Item 2(a)-(c).

Name of Person Filing; Address of Principal Business Office; and Citizenship

i)	OCM Value SPAC Holdings, L.P., a Delaware limited partnership (“OCM Value SPAC”), no longer holds any beneficial ownership of the common stock of the Issuer;

ii)	Oaktree Fund GP, LLC, a Delaware limited liability company (“Fund GP”), in its capacity as the general partner of OCM Value SPAC;

iii)	Oaktree Fund GP I, L.P., a Delaware limited partnership (“GP I”), in its capacity as the managing member of Fund GP;

iv)	Oaktree Capital I, L.P., a Delaware limited partnership (“Capital I”), in its capacity as the general partner of GP I;

v)	OCM Holdings I, LLC, a Delaware limited liability company (“Holdings I”), in its capacity as the general partner of Capital I;

vi)	Oaktree Holdings, LLC, a Delaware limited liability company (“Holdings”), in its capacity as the managing member of Holdings I;

vii)	Oaktree Capital Group, LLC, a Delaware limited liability company (“OCG”), in its capacity as the managing member of Holdings;

viii)

Oaktree Capital Group Holdings GP, LLC, a Delaware limited liability company (“OCGH GP”), in its capacity as the indirect owner of the class B units of OCG;

ix)	Brookfield Corporation (f/k/a Brookfield Asset Management, Inc.), an Ontario corporation (“BAM”), in its capacity as the indirect owner of the class A units of OCG; and

x)	BAM Partners Trust, a trust established under the laws of Ontario (the “BAM Partnership”), in its capacity as the sole owner of Class B Limited Voting Shares of BAM.

Item 2(d).

Title of Class of Securities:

Item 2(e).

CUSIP Number:

Item 3.

If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

Item 4.

Ownership:

Pursuant to Rule 13d-4 of the Exchange Act, the Reporting Persons declare that filing this Statement shall not be construed as an admission that any such person is, for the purposes of Section 13(d) and/or Section 13(g) of the Exchange Act, the beneficial owner of any securities covered by this Statement except to the extent of such person’s pecuniary interest in the units, and except to the extent of its pecuniary interest, such beneficial ownership is expressly disclaimed by each Reporting Person.  

Item 5.

Ownership of Five Percent or Less of a Class:

Item 6.

Ownership of More than Five Percent on Behalf of Another Person:

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:

Item 8.

Identification and Classification of Members of the Group:

Item 9.

Notice of Dissolution of Group:

Item 10.

Certification:

	OCM VALUE SPAC HOLDINGS, L.P.
	By:	OAKTREE FUND GP, LLC
	Its:	General Partner
	By:	/s/ Henry Orren
	Name:	Henry Orren
	Title:	Authorized Signatory
	OAKTREE FUND GP, LLC
	By:	Oaktree Fund GP I, L.P.
	Its:	Managing Member
	By:	/s/ Henry Orren
	Name:	Henry Orren
	Title:	Authorized Signatory
	OAKTREE FUND GP I, L.P.
	By:	/s/ Henry Orren
	Name:	Henry Orren
	Title:	Authorized Signatory
	OAKTREE CAPITAL I, L.P.
	By:	/s/ Henry Orren
	Name:	Henry Orren
	Title:	Senior Vice President

	OCM HOLDINGS I, LLC
	By:	/s/ Henry Orren
	Name:	Henry Orren
	Title:	Senior Vice President
	OAKTREE HOLDINGS, LLC
	By:	/s/ Henry Orren
	Name:	Henry Orren
	Title:	Senior Vice President
	OAKTREE CAPITAL GROUP, LLC
	By:	/s/ Henry Orren
	Name:	Henry Orren
	Title:	Senior Vice President
	OAKTREE CAPITAL GROUP HOLDINGS GP, LLC
	By:	/s/ Henry Orren
	Name:	Henry Orren
	Title:	Senior Vice President
	BROOKFIELD CORPORATION
	By:	/s/ Swati Mandava
	Name:	Swati Mandava
	Title:	Senior Vice President Legal & Regulatory
	BAM PARTNERS TRUST
	By:	BAM Class B Partners Inc.
	Its:	Trustee
	By:	/s/ Kathy Sarpash
	Name:	Kathy Sarpash
	Title:	Secretary

Exhibit 1.

Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.

---

ZyVersa Therapeutics (NASDAQ:ZVSA)
Historical Stock Chart
From Oct 2023 to Nov 2023

ZyVersa Therapeutics (NASDAQ:ZVSA)
Historical Stock Chart
From Nov 2022 to Nov 2023